aTyr Pharma (ATYR) Earnings Date & Reports

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ATYR is expected to report earnings to fall 28.09% to -15 cents per share on November 06

Q3'25

Est.

$-0.16

Q2'25

Missed

by $0.04

Q1'25

Beat

by $0.02

Q4'24

Beat

by $0.05

Q3'24

Missed

by $0.01

The last earnings report on August 07 showed earnings per share of -21 cents, missing the estimate of -18 cents. With 57.14K shares outstanding, the current market capitalization sits at 471.72M.

View a ticker or compare two or three

Compare

ATYR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ATYR
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ATYR showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details